Applied Therapeutics, Inc. (NASDAQ:APLT) Receives $6.10 Consensus PT from Analysts
Applied Therapeutics, Inc. (NASDAQ:APLT – Get Free Report) has been assigned an average recommendation of “Moderate Buy” from the six ratings firms that are presently covering the stock, MarketBeat reports. Three investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The average twelve-month target […]
Applied Therapeutics, Inc. (NASDAQ:APLT – Get Free Report) has been assigned an average recommendation of “Moderate Buy” from the six ratings firms that are presently covering the stock, MarketBeat reports. Three investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The average twelve-month target […]
